- About Pancreatic Cancer
- Get Support
Caregivers
- Get Involved
- Events
- More
2017-12-19
2020-12-09
2020-12-19
36
NCT03328065
Centre Hospitalier Universitaire Dijon
Centre Hospitalier Universitaire Dijon
OBSERVATIONAL
Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine Tumours
Reflexion on the therapeutic strategies to implement in patients at the end of life is advancing rapidly in France. However, beyond the choices presented to patients, sometimes even the decision to carry on, to limit or to stop treatments is also questioned. This decision is subjective; it is influenced by the patient's representation system (emotions, beliefs, values, practices, etc). In addition, even though he or she is the focus of the decision, the patient is not alone; other actors, accompanying the patient, play an important role in the final decision making. These actors, namely the doctors and close relatives, are also influenced in their decision making. This coexistence of representation systems may interfere with objective indicators that help in decision making (functional, clinical and biological) or with the knowledge acquired by doctors in their training and may complicate the decision-making process.
N/A
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
| Study Registration Dates | Results Reporting Dates | Study Record Updates |
|---|---|---|
2017-10-04 | N/A | 2022-04-14 |
2017-10-27 | N/A | 2022-04-21 |
2017-11-01 | N/A | 2022-04 |
This section provides details of the study plan, including how the study is designed and what the study is measuring.
Primary Purpose:
N/A
Allocation:
N/A
Interventional Model:
N/A
Masking:
N/A
Arms and Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
| : Stable patients, early responders to treatment and caregivers | OTHER: Interviews
OTHER: Questionnaires
|
| : Stable patients and intermediate responders and c Stable patients and intermediate responders to treatments and caregivers | OTHER: Interviews
OTHER: Questionnaires
|
| : Doctors | OTHER: Interviews
OTHER: Questionnaires
|
| : Patients in therapeutic escape and their caregivers | OTHER: Interviews
OTHER: Questionnaires
|
| Primary Outcome Measures | Measure Description | Time Frame |
|---|---|---|
| Number of determinants which are privileged by the patients to choose a treatment | through study completion, an average of 18 months | |
| Type of determinants which are privileged by the patients to choose a treatment | through study completion, an average of 18 months |
| Secondary Outcome Measures | Measure Description | Time Frame |
|---|
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.
Ages Eligible for Study:
ALL
Sexes Eligible for Study:
Accepts Healthy Volunteers:
1
This is where you will find people and organizations involved with this study.
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
No publications available
